Enochian Biosciences, Inc.

Enochian Biosciences, Inc. is a pre-clinical stage biotechnology company specializing in the research and development of pharmaceutical and biological products for the treatment of HIV, HBV, influenza, coronavirus infections, and cancer. The company's lead candidates include autologous HIV curative treatment, preventative and therapeutic HIV vaccines, and a coopting HBV polymerase. Additionally, the company is developing off the shelf DC vaccines for multiple solid tumors and non-specific vaccines for intratumoral injection. Enochian Biosciences, Inc. generates revenue through strategic partnerships with leading research institutions and the development of innovative pharmaceutical and biological products.

Products

• Autologous HIV curative treatment

• Preventative and therapeutic HIV vaccines

• Coopting HBV polymerase

• Off the shelf DC vaccines for multiple solid tumors

• Non-specific vaccines for intratumoral injection